Evidence map›Paper›PMID 23903848›Full record

ArticleJournal of virology2013

Isolate-specific differences in the conformational dynamics and antigenicity of HIV-1 gp120.

Thaddeus M Davenport, Miklos Guttman, Wenjin Guo, Brad Cleveland, Maria Kahn, Shiu-Lok Hu, Kelly K Lee

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Structure of the immature Zika virus at 9 Å resolution.Nature structural & molecular biology · 2017
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thaddeus M DavenportDepartment of Global Health.
Miklos Guttman
Wenjin Guo
Brad Cleveland
Maria Kahn
Shiu-Lok Hu
Kelly K Lee
University of Washington · US

Funding

YILMA SIV VACCINIA VACCINE TRIALP51RR000166 · NCRR · UNIVERSITY OF WASHINGTON · PI BAILLIE, THOMAS ALLAN · 1985 to 2011
$161.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Latesha Ellen Elopre · 1988 to 2026
$84.1M
ZWITTERION SURFACTANT DDMAB FOR IMPROV STABIL OF PROTEINP41RR001209 · NCRR · STANFORD UNIVERSITY · PI SCOTT, EMILY E · 1985 to 2011
$38.9M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Waters ACQUITY UPLC M-Class with NanoLockSpray ionization sourceR01GM099989 · NIGMS · UNIVERSITY OF WASHINGTON · PI LEE, KELLY KEISEN · 2012 to 2020
$3.5M
Glycan modification, CD4 independence, and Env immunogenicityR01AI076170 · NIAID · UNIVERSITY OF WASHINGTON · PI HU, SHIU-LOK · 2008 to 2011
$3.0M
Influenza Hemagglutinin: Structure, Dynamics, and Cooperativity During FusionR00GM080352 · NIGMS · UNIVERSITY OF WASHINGTON · PI LEE, KELLY KEISEN · 2009 to 2011
$740k
NCRR NIH HHS P01-RR000166NCRR NIH HHS P41 RR001209NCRR NIH HHS P41-RR001209NCRR NIH HHS P51 RR000166NIAID NIH HHS P30 AI027767NIAID NIH HHS P30-AI027767NIAID NIH HHS R01 AI076170NIAID NIH HHS R01-AI076170NIAID NIH HHS T32 AI007509NIAID NIH HHS T32-AI7509NIGMS NIH HHS R00 GM080352NIGMS NIH HHS R00-GM080352NIGMS NIH HHS R01 GM099989NIGMS NIH HHS R01-GM099989
6 · The paper itself

Abstract

The HIV-1 envelope glycoprotein (Env) mediates viral entry into host cells and is the sole target of neutralizing antibodies. Much of the sequence diversity in the HIV-1 genome is concentrated within Env, particularly within its gp120 surface subunit. While dramatic functional diversity exists among HIV-1 Env isolates-observable even in the context of monomeric gp120 proteins as differences in antigenicity and immunogenicity-we have little understanding of the structural features that distinguish Env isolates and lead to isolate-specific functional differences, as crystal structures of truncated gp120 "core" proteins from diverse isolates reveal a high level of structural conservation. Because gp120 proteins are used as prospective vaccine immunogens, it is critical to understand the structural factors that influence their reactivity with antibodies. Here, we studied four full-length, glycosylated gp120 monomers from diverse HIV-1 isolates by using small-angle X-ray scattering (SAXS) to probe the overall subunit morphology and hydrogen/deuterium-exchange with mass spectrometry (HDX-MS) to characterize the local structural order of each gp120. We observed that while the overall subunit architecture was similar among isolates by SAXS, dramatic isolate-specific differences in the conformational stability of gp120 were evident by HDX-MS. These differences persisted even with the CD4 receptor bound. Furthermore, surface plasmon resonance (SPR) and enzyme-linked immunosorbance assays (ELISAs) showed that disorder was associated with poorer recognition by antibodies targeting conserved conformational epitopes. These data provide additional insight into the structural determinants of gp120 antigenicity and suggest that conformational dynamics should be considered in the selection and design of optimized Env immunogens.

Indexed as

AIDS VaccinesAntibodies, NeutralizingAntigens, ViralCD4 AntigensDeuterium Exchange MeasurementDrug DesignEpitopesGlycosylationHIV AntibodiesHIV Envelope Protein gp120HumansProtein ConformationScattering, Small AngleSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSurface Plasmon ResonanceAIDS VaccinesAntibodies, NeutralizingAntigens, ViralCD4 AntigensEpitopesHIV AntibodiesHIV Envelope Protein gp120

Identifiers

PMID23903848
PMCPMC3807424
OpenAlexW2168314748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.